Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Other Income (Expense) : E£72 Mil (TTM As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Other Income (Expense)?

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's other income expense for the Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's pretax income for the three months ended in Dec. 2024 was E£21 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2024 was E£72 Mil.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Other Income (Expense) Historical Data

The historical data trend for Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Other Income (Expense) Chart

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Income (Expense)

Get a 7-Day Free Trial

-2.48

-0.66

27.92

22.35

72.10

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Income (Expense)	Get a 7-Day Free Trial															3.45	47.55	7.52	-4.23	21.25

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was E£72 Mil.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) » Definitions » Other Income (Expense)

Traded in Other Exchanges

N/A

Address

No. 5 Second Industrial Zone, Sixth of October City, Giza, EGY

Website

https://www.ramedapharma.com

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents is a pharmaceutical company. The company is engaged in the manufacturing, marketing, selling, and storage of pharmaceutical reagents for both human and veterinary use. It is also involved in manufacturing, marketing, selling and storing diagnostic and pharmaceutical reagents for human, veterinary, and diagnostic use.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Headlines

No Headlines